Screener
Cullinan Therapeutics, Inc. CGEM Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s retained earnings?
- Cullinan Therapeutics, Inc. (CGEM) reported retained earnings of -$691.48M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s retained earnings changed year-over-year?
- Cullinan Therapeutics, Inc.'s retained earnings decreased by 42.0% year-over-year, from -$486.8M to -$691.48M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s retained earnings has grown at a 44.5% compound annual growth rate (CAGR), from -$93.34M to -$588.12M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Cullinan Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude